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Abstract Aim of the study was to evaluate the elasto-
graphic appearance of medullary thyroid carcinoma (MTC)
by a retrospective evaluation of 18 nodules histologically
proven as MTC. Free-hand qualitative elastography was
performed using Hitachi Logos EUB 7500. The elasticity
score (ES), was assessed based on a colour elastogram, the
blue colour being correlated with hard tissue, red colour
with soft tissue, and green with intermediate hardness.
Nodules were classified into four classes. A alleged diag-
nosis of malignancy was assigned to nodules with ES3 or 4
and a presumptive diagnosis of benignity was assigned to
nodules with an ES1 or 2. More than half (55.6 %) of
MTCs have a low-intermediate grade of elasticity. The
hardest lesions (ES4) were those with ultrasonographic
features highly suspicious for malignancy. In conclusion,
most of MTCs present an elastographic pattern of benig-
nity. Therefore, qualitative elastography does not add
useful information in pointing out MTC on the basis of its
hardness. Our data suggest a marginal role for this tech-
nique in MTC evaluation.
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Introduction
Thyroid nodules are a very common entity, being detect-
able in up to 67 % of subjects by ultrasonography (US).
Approximately 5 % of all thyroid lesions are cancer [1].
Then, the first aim in thyroid nodule evaluation is to
exclude malignancy, which includes differentiated thyroid
cancer, medullary cancer (MTC) and, more rarely, ana-
plastic carcinoma and lymphoma [1]. Cytological exami-
nation of material obtained by fine-needle cytology, due to
its high sensitivity and specificity, is the best single test for
differential diagnosis. However, there is a recognized 5 %
false-negative rate and it has the disadvantage of being an
invasive procedure. Therefore, recently, US elastography
(USE), a novel technology based on the elastic property of
the tissue, has been added to the diagnostic armamentarium
as an accurate, non-invasive predictor of thyroid malig-
nancy. The technique is based on the principle that
malignant lesions are harder than benign ones.
Several studies on thyroid USE have been reported since
its first evaluation in thyroid context in 2005 and they
generally consider USE useful in detecting malignant
lesions [2]. Nevertheless, the majority of these studies
focused on differentiated papillary carcinoma (PTC), the
most common thyroid cancer. On the contrary, USE
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features of MTC are incidentally reported only in few
reports. In the present study, we examined the elasto-
graphic features of MTC and discussed the role of USE in
this kind of thyroid cancer.
Patients and methods
Eighteen consecutive MTCs were retrospectively enrolled
from three different Institutes: seven cases at Istituto
Auxologico Italiano of Milan, other seven cases at Yoko-
hama Northern Hospital, and four cases at Ospedale Is-
raelitico of Rome. All MTC lesions were assessed by free-
hand real-time qualitative USE. Qualitative thyroid USE
was performed, before fine-needle cytology and surgery,
using Hitachi Logos EUB 7500, and 6–13 MHz linear
probes according to the technique previously described [3],
by three experienced examiners (MA, PT, NF).
The USE score, i.e. elasticity score (ES), was assessed
based on a colour elastogram, the blue colour being corre-
lated with hard tissue, red with soft tissue, and green with
intermediate hardness. Nodules were classified into four
classes: ES1: lesion homogeneously red or green; ES2: green
displayed in more than half of nodule; ES3: blue displayed in
more than half of lesion; ES4: nodule homogenously blue
[3]. An alleged diagnosis of malignancy was assigned to
nodules with ES 3 or 4, and a presumptive diagnosis of be-
nignity was assigned to nodules with an ES1 or 2. One
elastogram image for each MTC lesion was chosen, stored
and separately blindly evaluated by each operator. There-
fore, each MTC elastogram image received three provisional
elasticity scores. The final score is assigned on the basis of
the prevalent temporary elasticity score. In case of entirely
discordant provisional scores, e.g. three different scores, a
collegial re-examination of the recorded pictures was fore-
seen in order to reach a shared ES.
Results
Owing to the lack of entirely discordant cases a collegial
revaluation was never required.
ES was 1 in 1/18 nodules (5.6 %), 2 in 9/18 lesions
(50.0 %), 3 in 4/18 nodules (22.2 %), and 4 in the remaining
4 tumours (22.2 %) (Fig. 1a). The prevalent USE pattern of
MTC was ES 2, and according to our criteria, the majority of
MTCs (55.6 %) presented an elastographic pattern of be-
nignity (Fig. 1b). Moreover, the hardest lesions (ES4) were
those with other ultrasonographic features highly suspicious
for malignancy (Fig. 1c).
Discussion
Due to its ability in documenting hard lesions, USE has
been proposed as an useful non-invasive tool in predicting
PTC, the most common thyroid tumour, even if classical
ultrasound features of malignancy are lacking [2]. Instead,
data on the USE features of MTC are lacking, though an
early diagnosis is strongly recommended due to its
aggressive behaviour. Moreover, the possible pitfalls of
cytology [4] and the reported low prevalence of suspicious
ultrasound features [5], represent common causes of mis-
sed presurgical diagnosis of MTC. Therefore, USE would
represent an additional useful tool and we tested its pre-
dictive reliability in this scenario. To the best of our
Fig. 1 a The distribution of 18 MTC nodules in the four elastografic
classes. b The most frequent elastographic pattern showed by MTC
(ES2). This lesion is solid, isoechoic, homogenous and presents
regular margins at standard ultrasonography and it appears green in
more than half of its surface. c A hard MTC lesion (ES4). The tumour
is homogenously blue and therefore suspicious for malignancy.
Nevertheless, this lesion was suspicious for malignancy due to its
marked hypoechogenicity and the presence of irregular and spiculated
margins at standard ultrasound evaluation
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knowledge, this is the first report focusing on the USE
features of MTCs.
The major finding of our study is that more than half of
MTCs have a low-intermediate grade of elasticity, in
contrast with reports on PTCs [2]. Most of the MTCs
present an elastographic pattern of benignity suggesting
that most of the MTC lesions are not hard. Indeed, the
hardest medullary lesions (ES4) were those with other US
features suggestive of malignancy in our series.
The number of samples here examined is limited sug-
gesting the need of largest prospective studies involving
subjects bearing also other thyroid malignancies and
benignant nodules. Moreover, the use of more precise USE
methods, such as the semiquantitative Strain Ratio-USE
and the quantitative Shear Wave-USE, may improve the
accuracy of USE in this setting [6, 7]. However, because of
the lack of data focusing on USE presentation of MTC, the
present data represent a novelty on this topic. In conclu-
sion, qualitative-USE does not appear to add useful infor-
mation and does not overcome the diagnostic limits of US
and cytology in MTC [4, 5]. Our results indirectly support
the diagnostic importance of routine serum calcitonin
measurement in nodular thyroid disease.
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